(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SIRNAOMICS ADVANCING RNAI THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SIRNAOMICS ADVANCING RNAI THERAPEUTICS

ST13

US500000090837223

Class

5

Filing

90837223

Registration

7469259

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

08/06/2024

Trademark type

Combined

Nice classes

5

Filing date

07/20/2021

Registration date

08/06/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/06/2024

Last transaction

08/06/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/01/2023

First use in commerce

01/01/2023

Drawing code

3

Owner type

03

Owner location

Germantown, MD

Examiner

WILSON, MARYNELLE WEST

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "SIRNAOMICS" with a round medicinal tablet replacing the "O" above the stylized wording "ADVANCING RNAI THERAPEUTICS". A curved band is above the word "SIRNAOMICS" connecting the dots on the "I"s.

Holders and representatives

Holders

Sirnaomics, Inc.
Sirnaomics, Inc.

Representatives

Leesa N. Weiss Edell, Shapiro & Finnan, LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Drug delivery agents in the form of a coating for nanoparticle polymers that facilitate the delivery of a wide range of pharmaceuticals; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/06/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/01/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/01/2024

ALIE

ASSIGNED TO LIE

07/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

09/28/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

09/28/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/28/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/28/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/28/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/28/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/28/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/10/2023

GNRT

NON-FINAL ACTION E-MAILED

07/10/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

07/10/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/12/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/09/2023

IUAF

USE AMENDMENT FILED

05/18/2023

EISU

TEAS STATEMENT OF USE RECEIVED

05/18/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/29/2022

NEWN

NEW NOA TO ISSUE

10/17/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/28/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/26/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/31/2022

PUBO

PUBLISHED FOR OPPOSITION

05/31/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/11/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/25/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

04/25/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/25/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

04/25/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/25/2022

DOCK

ASSIGNED TO EXAMINER

04/13/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/22/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/21/2021

NWAP

NEW APPLICATION ENTERED

07/23/2021

Continuous trademark protection

Get notified about every new filing that threatens SIRNAOMICS ADVANCING RNAI THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.